The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine.

The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine. Curator and Reporter: Dr. Premalata Pati, Ph.D., Postdoc Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), Part of National Institute of Health (NIH) said, Ending a global pandemic demands a global response. I am thrilled that a novel vaccine … Continue reading The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine.